SBC Medical Group (NASDAQ:SBC) Releases Earnings Results, Beats Expectations By $0.03 EPS

Key Points

• SBC Medical Group reported quarterly EPS of $0.15, beating the $0.12 consensus, and revenue of $58.58 million, above estimates of $48.90 million.
• Revenue grew 35% year over year; operating income and Adjusted EBITDA each rose 66%, with Adjusted EBITDA margin expanding 9 percentage points to 47%.
• The clinic network expanded to 293 locations, up 36 from a year earlier. Management plans to prioritize clinic openings and acquisitions over share buybacks for now.

SBC Medical Group (NASDAQ:SBC - Get Free Report) issued its earnings results on Friday. The company reported $0.15 EPS for the quarter, beating analysts' consensus estimates of $0.12 by $0.03, FiscalAI reports. SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%. The firm had revenue of $58.58 million for the quarter, compared to analyst estimates of $48.90 million.

Here are the key takeaways from SBC Medical Group's conference call:

• Q3 growth and margins accelerated: Revenue rose 35% year over year to $59 million, while operating income and Adjusted EBITDA each increased 66%; Adjusted EBITDA margin expanded 9 percentage points to 47%. Management attributed growth partly to revised service fees, equipment-related rental revenue, and the newly consolidated Waqoo segment.
• Existing clinics and the network both grew: Nine-month same-clinic revenue increased 7%, with visits up 9% and average spend per visit up 4%; the network reached 293 locations. Management expects clinic expansion to continue and cited plans to grow general-medicine services and pursue acquisitions.
• AI and longevity are longer-term growth opportunities: SBC is developing diagnostic tests and AI tools for clinic operations and personalized care, with longevity services targeted to contribute meaningfully from around 2028. Management expects AI and network scale to support further margin improvement, but did not quantify the impact or timing.
• No additional share buybacks are planned for now: Despite cash exceeding $200 million, management said it will prioritize acquisitions and new clinic openings, while continuing to focus on improving liquidity.
• Liquidity has improved, while governance changes remain in progress: October average daily trading value was about $1 million, 4.1 times July’s level, and the shareholder base grew 1.6 times. Management said it is advancing the selection of independent directors, but gave no appointment date.

SBC Medical Group Price Performance

Shares of SBC Medical Group stock traded up $1.95 during trading hours on Friday, reaching $7.29. The stock had a trading volume of 1,483,006 shares, compared to its average volume of 128,669. The stock's 50 day moving average is $5.07 and its 200 day moving average is $3.96. The firm has a market capitalization of $749.78 million, a PE ratio of 15.51, a PEG ratio of 2.36 and a beta of 0.52. SBC Medical Group has a twelve month low of $2.78 and a twelve month high of $7.35. The company has a current ratio of 3.31, a quick ratio of 3.27 and a debt-to-equity ratio of 0.09.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on SBC shares. BTIG Research reissued a "buy" rating and set a $8.00 price target on shares of SBC Medical Group in a research report on Thursday, August 13th. Wall Street Zen raised shares of SBC Medical Group from a "buy" rating to a "strong-buy" rating in a report on Monday, October 5th. Finally, Weiss Ratings raised shares of SBC Medical Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, October 9th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, SBC Medical Group presently has an average rating of "Moderate Buy" and an average target price of $8.00.

SBC Medical Group News Summary

Investors following SBC have been watching these news items:

• Positive Sentiment: Q3 revenue rose 35% year over year to $58.6 million, beating analyst expectations of $48.9 million. EPS of $0.15 also topped the $0.12 consensus estimate. Net income attributable to SBC increased 22% to $15.7 million, while operating income climbed to $26.4 million from $15.9 million. SBC Medical Q3 financial results
• Positive Sentiment: Growth was supported by higher management-services revenue, service-fee revisions and the consolidation of Waqoo. SBC also expanded its clinic network by 36 locations year over year, to 293 locations. Q3 revenue and operating update
• Neutral Sentiment: For the first nine months of 2026, revenue increased 13% year over year to $150.8 million. SBC reported $198.4 million in cash and cash equivalents at September 30. Third-quarter and nine-month results

SBC Medical Group Company Profile

SBC Medical Group Holdings provides management and support services to medical institutions, with a focus on clinics offering aesthetic medicine. Its services include support for clinic operations, marketing, staff training, procurement and customer service, allowing affiliated medical providers to focus on patient care. The group is associated with the Shonan Beauty Clinic brand and a broader network of clinics offering services such as cosmetic surgery and dermatology. Its business is centered primarily in Japan, where it supports the operations and growth of affiliated medical institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.